NMZL gene expression signature: most relevant NMZL signature genes
Gene . | NMZL vs RLN comparison . | NMZL vs FL comparison . | Memory vs GC comparison . | Cytoband . | Description . | |||
---|---|---|---|---|---|---|---|---|
Fold change . | FDR . | Fold change . | FDR . | Fold change . | P . | |||
TACI* | 2.075 | 0.032 | 1.987 | 0.042 | 0.925 | < .001 | 17p11.2 | TNF receptor, B-cell stimulation. NF-κB activator |
CHIT1* | 2.044 | NS (0.072) | 2.527 | 0.020 | −0.234 | NS | 1q31-q32 | Microenvironment involved |
CD82* | 2.045 | 0.012 | 1.727 | 0.027 | 0.399 | NS | 11p11.2 | Coactivator for the BCR pathway |
CHI3L1 | 1.588 | 0.028 | 1.635 | 0.029 | 0.133 | ND | 1q32.1 | Microenvironment involved |
CLPTM1 | 1.652 | 0.009 | 1.334 | 0.049 | 0.249 | ND | 19q13.32 | Lymphocyte activation |
PTPN1 | 1.487 | 0.008 | 1.243 | 0.026 | 0.245 | ND | 20q13.13 | Signal transduction |
TRAF4 | 1.036 | 0.033 | 1.139 | 0.022 | −0.110 | ND | 17q11.2 | TNF receptor-associated factor; NF-κB activation |
TGF-β1* | 1.175 | 0.010 | 1.009 | 0.025 | 0.371 | NS | 19q13.2 | Cell proliferation and differentiation |
CD44* | 0.874 | 0.029 | 1.285 | 0.006 | 1.131 | NS | 11p13 | Adhesion molecule related to marginal zone |
SMAD2 | −0.837 | 0.010 | −0.712 | 0.030 | 0.000 | ND | 18q21.1 | TGF-β signaling pathway |
HDAC2 | −1.258 | 0.007 | −1.016 | 0.013 | −0.171 | ND | 6q22.1 | Chromatin modification |
IKIP* | −1.428 | 0.029 | −1.270 | 0.045 | −0.179 | ND | 12q23.1 | Apoptosis |
RAD54B* | −1.775 | 0.007 | −1.291 | 0.026 | −0.241 | NS | 8q22.1 | DNA repair |
SMAD3 | −2.447 | 0.029 | −1.226 | 0.044 | 0.335 | ND | 6q23.1 | TGF-β signaling pathway |
LMO2* | −2.533 | 0.006 | −1.732 | 0.014 | −0.545 | NS | 11p13 | GC marker |
LEF1 | −2.828 | 0.009 | −1.768 | 0.021 | 1.682 | ND | 4q25 | Implicated in gene expression transcription |
CD10 | −4.269 | 0.006 | −2.172 | 0.041 | −0.612 | ND | 3q32.31 | GC marker |
Gene . | NMZL vs RLN comparison . | NMZL vs FL comparison . | Memory vs GC comparison . | Cytoband . | Description . | |||
---|---|---|---|---|---|---|---|---|
Fold change . | FDR . | Fold change . | FDR . | Fold change . | P . | |||
TACI* | 2.075 | 0.032 | 1.987 | 0.042 | 0.925 | < .001 | 17p11.2 | TNF receptor, B-cell stimulation. NF-κB activator |
CHIT1* | 2.044 | NS (0.072) | 2.527 | 0.020 | −0.234 | NS | 1q31-q32 | Microenvironment involved |
CD82* | 2.045 | 0.012 | 1.727 | 0.027 | 0.399 | NS | 11p11.2 | Coactivator for the BCR pathway |
CHI3L1 | 1.588 | 0.028 | 1.635 | 0.029 | 0.133 | ND | 1q32.1 | Microenvironment involved |
CLPTM1 | 1.652 | 0.009 | 1.334 | 0.049 | 0.249 | ND | 19q13.32 | Lymphocyte activation |
PTPN1 | 1.487 | 0.008 | 1.243 | 0.026 | 0.245 | ND | 20q13.13 | Signal transduction |
TRAF4 | 1.036 | 0.033 | 1.139 | 0.022 | −0.110 | ND | 17q11.2 | TNF receptor-associated factor; NF-κB activation |
TGF-β1* | 1.175 | 0.010 | 1.009 | 0.025 | 0.371 | NS | 19q13.2 | Cell proliferation and differentiation |
CD44* | 0.874 | 0.029 | 1.285 | 0.006 | 1.131 | NS | 11p13 | Adhesion molecule related to marginal zone |
SMAD2 | −0.837 | 0.010 | −0.712 | 0.030 | 0.000 | ND | 18q21.1 | TGF-β signaling pathway |
HDAC2 | −1.258 | 0.007 | −1.016 | 0.013 | −0.171 | ND | 6q22.1 | Chromatin modification |
IKIP* | −1.428 | 0.029 | −1.270 | 0.045 | −0.179 | ND | 12q23.1 | Apoptosis |
RAD54B* | −1.775 | 0.007 | −1.291 | 0.026 | −0.241 | NS | 8q22.1 | DNA repair |
SMAD3 | −2.447 | 0.029 | −1.226 | 0.044 | 0.335 | ND | 6q23.1 | TGF-β signaling pathway |
LMO2* | −2.533 | 0.006 | −1.732 | 0.014 | −0.545 | NS | 11p13 | GC marker |
LEF1 | −2.828 | 0.009 | −1.768 | 0.021 | 1.682 | ND | 4q25 | Implicated in gene expression transcription |
CD10 | −4.269 | 0.006 | −2.172 | 0.041 | −0.612 | ND | 3q32.31 | GC marker |
Fold changes corresponding to the log2 difference between the NMZL and RLN, NMZL, and FL, and memory B-cell and GC B-cell averages, respectively. FDR and P values are from the t test (http://pomelo2.bioinfo.cnio.es/).
NS indicates not significant; and ND, not determined.
To validate the microarray data, the gene was included in the quantitative RT-PCR assay.